urokinase-type plasminogen activator (9)
biomarkers, tumor (8)
plasminogen activator inhibitor 1 (8)
breast neoplasms (7)
gestational trophoblastic disease (7)
neoplasms (4)
chorionic gonadotropin (3)
antineoplastic combined chemotherapy protocols (2)
carcinoma, squamous cell (2)
endothelial growth factors (2)
enzyme-linked immunosorbent assay (2)
ethanol (2)
hallucinogens (2)
lung neoplasms (2)
methylenedioxymethamphetamine (2)
neoplasm metastasis (2)
neoplasm proteins (2)
receptors, cell surface (2)
tissue plasminogen activator (2)
adrenal gland neoplasms (1)
adrenal glands (1)
antibiotics, antineoplastic (1)
antibodies, monoclonal, humanized (1)
antimetabolites, antineoplastic (1)
anxiety (1)
atypical hemolytic uremic syndrome (1)
bariatric surgery (1)
biological assay (1)
biological markers (1)
biometry (1)
brain neoplasms (1)
calcitriol (1)
calcium channel agonists (1)
calcium channels (1)
carcinoma (1)
chromosome deletion (1)
chromosomes, human, pair 1 (1)
clinical laboratory techniques (1)
clinical trials as topic (1)
clonidine (1)
complement inactivating agents (1)
cryopreservation (1)
cytokines (1)
dactinomycin (1)
depression (1)
endotoxemia (1)
estradiol (1)
gene expression regulation, neoplastic (1)
genetic variation (1)
glioma (1)